» Articles » PMID: 39091436

Identification of Key Genes Associated with Polycystic Ovarian Syndrome and Endometrial and Ovarian Cancer Through Bioinformatics

Overview
Date 2024 Aug 2
PMID 39091436
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Polycystic ovary syndrome (PCOS), a common endocrine disorder, is linked to increased risks of endometrial cancer (EC) and ovarian cancer (OC). Our study utilises bioinformatics analysis to identify shared gene signatures and elucidate biological processes between EC and OC and PCOS.

Aim: The objective of this research is to unveil the common molecular landscape shared by PCOS and EC and OC.

Settings And Design: An observational computational bioinformatics analysis.

Materials And Methods: Gene expression profiles for PCOS (GSE199225), EC (GSE215413) and OC (GSE174670) were obtained from the Gene Expression Omnibus database. Hub genes were identified through functional enrichment analysis and protein-protein interaction. Drug identification analyses were employed to find drugs targeting the hub genes.

Results: Key hub genes linking PCOS and EC includes and ; for PCOS and OC, they include and . Gene Ontology analysis revealed DNA metabolic process in PCOS and EC, while in PCOS and OC, it identified the removal of superoxide radicals. Kyoto Encyclopaedia of Genes and Genomes pathway analysis highlighted cell cycle in PCOS and EC and hepatocellular carcinoma in PCOS and OC. Potential drugs for PCOS and EC include quercetin, calcitriol and testosterone; for PCOS and OC, eugenol and 1-chloro-2,4-dinitrobenzene are identified.

Conclusion: These findings offer insights into potential therapeutic targets and pathways linking PCOS with EC and OC, enhancing our understanding of the molecular mechanisms involved in these associations.

References
1.
Chen E, Tan C, Kou Y, Duan Q, Wang Z, Meirelles G . Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013; 14:128. PMC: 3637064. DOI: 10.1186/1471-2105-14-128. View

2.
Che M, Wang R, Li X, Wang H, Zheng X . Expanding roles of superoxide dismutases in cell regulation and cancer. Drug Discov Today. 2015; 21(1):143-149. PMC: 4724522. DOI: 10.1016/j.drudis.2015.10.001. View

3.
Patil A, Hsieh T . Ribosomal Protein S3 Negatively Regulates Unwinding Activity of RecQ-like Helicase 4 through Their Physical Interaction. J Biol Chem. 2017; 292(10):4313-4325. PMC: 5354493. DOI: 10.1074/jbc.M116.764324. View

4.
Quintela M, James D, Pociute A, Powell L, Edwards K, Coombes Z . Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells. Clin Epigenetics. 2023; 15(1):63. PMC: 10105475. DOI: 10.1186/s13148-023-01477-x. View

5.
. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1):19-25. DOI: 10.1016/j.fertnstert.2003.10.004. View